Skip to main content
Log in

Hyperlipidemia in acute pancreatitis

Cause or epiphenomenon?

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Abstract

Whether hyperlipidemia is a pre-existing metabolic disorder or a consequence of acute pancreatitis is still debated. Mild to moderate elevation of serum triglyceride levels are likely to be an epiphenomenon of the pancreatic disease. A marked hyperchylomicronemia and hypertrygliceridemia would be needed to trigger acute pancreatitis; a relevant defect in the lipid catabolism and clearance should therefore pre-exist. The aim of the present study was to investigate whether patients with acute pancreatitis and marked hyperlipidemia have an impaired clearance capacity of exogenous lipids, which would define the hyperlipidemia as a preexistent abnormality and therefore a potential cause of the pancreatic disease. With this aim, the kinetics of the removal of exogenous triglycerides from the circulation have been analyzed. Twenty patients with acute pancreatitis have been studied. Ten of them suffered from an episode of acute pancreatitis with marked hyperlipidemia (serum triglyceride levels>20mmol/L). Four to six months after recovery from the pancreatitis, a two-stage infusion of Intralipid 20% was carried out and the fractional removal rate (K2) and the maximal clearance capacity (K1) of exogenous triglycerides were calculated. At low infusion rates a first order kinetics for removal was observed, whereas at high infusion rates a zero order kinetics was operating. All patients with a previous attack of normolipidemic acute pancreatitis had normal K2 and K1 values. Five patients with previous hyperlipidemic acute pancreatitis had an abnormally low clearance capacity of exogenous triglycerides, whereas the remaining five had normal removal values. The present study provides new information in the association between hyperlipidemia and acute pancreatitis by showing that even a marked elevation of serum lipid levels should not be invariably considered as the etiological factor of the pancreatic disease, even if other potential causes are not evident.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Domínguez-Muñoz JE, Malfertheiner P, Ditschuneit HH, et al. Hyperlipidaemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease.Int J Pancreatol 1991; 10: 261–267.

    PubMed  Google Scholar 

  2. Cameron JL, Capuzzi DM, Zuidema DG, Margolis S. Acute pancreatitis with hyperlipidaemia: The incidence of lipid abnormalities in acute pancreatitis.Ann Surg 1973; 177: 483–489.

    Article  PubMed  CAS  Google Scholar 

  3. Dickson AP, O’Neill J, Imrie CW. Hyperlipidaemia, alcohol abuse and acute pancreatitis.Br J Surg 1984; 71: 685–688.

    Article  PubMed  CAS  Google Scholar 

  4. Greenberger NJ. Pancreatitis and hyperlipidaemia.N Engl J Med 1973; 289: 586, 587.

    Article  PubMed  CAS  Google Scholar 

  5. Ditschuneit H. Hyperlipoproteinemia in the pathogenesis of acute pancreatitis, inAcute Pancreatitis, Beger HG, Büchler M, eds. Springer, Berlin-Heidelberg 1987; pp. 32–40.

    Google Scholar 

  6. Buch A, Buch J, Carlsen A, Schmidt A. Hyperlipidaemia and pancreatitis.World J Surg 1980; 4: 307–314.

    Article  PubMed  CAS  Google Scholar 

  7. Farmer RG, Winkleman EI, Brown HB, et al. Hyperlipoproteinemia and pancreatitis.Am J Med 1973; 54: 161.

    Article  PubMed  CAS  Google Scholar 

  8. Lewis B. Hyperlipidaemia, inthe Metabolic and Molecular Basis of Acquired Disease, Cohen RD, Lewis B, Alberti KGMM, Denman AM, eds. Baillière-Tindal: London 1990; pp. 860–920.

    Google Scholar 

  9. Toskes PP. Hyperlipidemic pancreatitis.Gastroenterol Clin North Am 1990; 19: 783–791.

    PubMed  CAS  Google Scholar 

  10. Durrington PN, Cairns SA. Acute pancreatitis: a complication of beta-blockade.Br Med J 1982; 284: 1016.

    Article  CAS  Google Scholar 

  11. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipaemia. Evidence for a persistent defect in lipid metabolism.Am J Med 1974; 56: 482–487.

    Article  PubMed  CAS  Google Scholar 

  12. Guzman S, Nervi F, Llanos O, Leon P, Valdivieso V. Impaired lipid clearance in patients with previous acute pancreatitis.Gut 1985; 26: 888–891.

    Article  PubMed  CAS  Google Scholar 

  13. Rollán A, Guzmán S, Pimentel F, Nervi F. Catabolism of chylomicron remnants in patients with previous acute pancreatitis.Gastroenterology 1990; 98: 1649–1654.

    PubMed  Google Scholar 

  14. Durrington PN, Twentyman OP, Braganza JM, Miller JP. Hypertriglyceridaemia and abnormalities of triglycerides catabolism persisting after acute pancreatitis.Int J Pancreatol 1986; 1: 195–203.

    PubMed  CAS  Google Scholar 

  15. Ehrlich EW, Spitzer JJ, Howard JM. Pancreatitis with hyperlipaemia.Surg Forum 1960; 11: 373.

    PubMed  CAS  Google Scholar 

  16. Wang C, Adlersberg D, Feldman EB. Serum lipids in acute pancreatitis.Gastroenterology 1959; 36: 832.

    PubMed  CAS  Google Scholar 

  17. Stackhouse KC, Glass DD, Zimmerman B. Relationships of lipoprotein lipase and hyperlipidaemia in pancreatitis.Surg Forum 1966; 17: 343.

    PubMed  CAS  Google Scholar 

  18. Wang C, Strauss L, Adlersberg D. Experimental pancreatitis and plasma lipids.Gastroenterology 1958; 35: 465.

    PubMed  CAS  Google Scholar 

  19. Haber PS, Wilson JS, Apte MV, Hall W, Goumas K, Pirola RC. Lipid intolerance does not account for susceptibility to alcoholic and gallstone pancreatitis.Gastroenterology 1994; 106: 742–748.

    PubMed  CAS  Google Scholar 

  20. Glueck CJ, Scheel D, Fishback J, Steiner P. Oestrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinaemia.Metabolism 1972; 21: 657–665.

    Article  PubMed  CAS  Google Scholar 

  21. Chait A, Mancini M, February AW, Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia.Lancet 1972; 2: 62–64.

    Article  PubMed  CAS  Google Scholar 

  22. Rössner S. Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid®.Acta Med Scand 1974; 196(suppl. 564): 1–24.

    Google Scholar 

  23. Kessler JI, Kniffen JC, Janowitz HD. Lipoprotein lipase inhibition in the hyperlipidaemia of acute pancreatitis.N Engl J Med 1963; 269: 943–948.

    Article  PubMed  CAS  Google Scholar 

  24. Kessler JI, Miller M, Barza D, Mishkin S. Hyperlipidaemia in acute pancreatitis.Am J Med 1967; 42: 968–976.

    Article  PubMed  CAS  Google Scholar 

  25. Lewis B, Boberg J, Mancini M, et al. Determination of the intravenous fat tolerance test with Intralipid by nephelometry.Atheroschlerosis 1972; 15: 83–86.

    Article  CAS  Google Scholar 

  26. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD, et al. Blood volume measurement: a critical study. Prediction of normal values.Adv Surg 1965; 1: 69–74.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Domínguez-Muñoz, J.E., Jünemann, F. & Malfertheiner, P. Hyperlipidemia in acute pancreatitis. Int J Pancreatol 18, 101–106 (1995). https://doi.org/10.1007/BF02785883

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785883

Key Words

Navigation